Standard BioTools Inc expected to post a loss of 12 cents a share - Earnings Preview

Standard BioTools

04/11/2023 01:31

* Standard BioTools Inc  LAB.OQ   LAB.O  is expected to show
a
fall in quarterly revenue when it reports  results 
    * The South San Francisco California-based  company is
expected to
report  a 6.2% decrease in revenue to $23.6 million from $25.17
million a year ago, according to the estimate from one analyst,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Standard BioTools
Inc is
for a loss of 12 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Standard
BioTools
Inc is $4​, above​ its last closing price of $2.09. ​​​

This summary was machine generated November 4 at 01:31 GMT.  All
figures in US dollars  unless otherwise stated